| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |